FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC),...
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC),...
/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...
Dr. Ali Raja, of Mass General, also talks about the FDA's approval of a new drug to protect babies and toddlers from RSV.
The FDA cleared once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter.
Jeffrey V. Matous, MD, discusses potential strategies to overcome barriers to receiving CAR T-cell therapy for patients with multiple myeloma, and how the potential use of these agents in earlier lines could improve infusion wait times and rates of disease progression.